We are monitoring the impact of COVID-19 on MEA Infectious Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1250
Share on
Share on

Middle East and Africa Infectious Disease Therapeutics Market Research Report – Segmented By Mode Of Treatment, Target Organism, Infection Type, Distribution Channels and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1250
Pages: 132

MEA Infectious Disease Therapeutics Market Size (2020 to 2025)

The size of the Middle East and Africa Infectious Disease Therapeutics Market was worth USD 8.42 Billion in 2020 and estimated to reach 12.29 USD Billion by the end of 2025, registering a CAGR of 7.877% between 2020 to 2025.

Bacteria, fungi, viruses, and parasites are some of the microorganisms causing infectious diseases such as malaria, HIV, tuberculosis, influenza. Inadequate personal hygiene and poor sanitation are the main reasons causing the infectious diseases. Anti-infective drugs are preventing the growth of the disease. Antibacterial, antifungal, antiparasitic, antiviral drugs are some of the anti- infective drugs used for the treatment of these diseases.

Growing incidence of infectious diseases, rising health care expenditure and growing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries are the factors that are driving the growth of Middle East and Africa Infectious disease Therapeutics Market. Generic erosion, Patent expiration of infectious disease drugs are the factors that are hampering the growth of the market.

This research report on the Middle East and Africa Infectious Disease Therapeutics Market has been segmented & sub-segmented into the following categories:

By Mode of Treatment:

  • Drugs     
  • Vaccines 

By Target Organism:

  • Antibacterial     
  • Antifungal
  • Antiviral 
  • Antiparasite     
  • Others    

By Infection type:

  • Bacterial 
  • Viral     
  • Fungal   
  • Parasitic 
  • Others  

By Distribution Channels:

  • Hospitals 
  • Clinics    
  • Others     

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Key market participants dominating the MEA Infectious disease Therapeutics Market covered in this report are F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, AstraZeneca, Auritec Pharmaceuticals, Bayer, Astellas Pharma, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Bristol-Myers Squibb and Sanofi.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Mode of Treatment                

                                5.1.1 Introduction           

                                5.1.2 Drugs        

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Topical

                                                5.1.2.3 Injections

                                                5.1.2.4 Others

                                5.1.3 Vaccines  

                                5.1.4 Y-o-Y Growth Analysis, By Mode of treatment         

                                5.1.5 Market Attractiveness Analysis, By Mode of treatment        

                                5.1.6 Market Share Analysis, By Mode of treatment         

                5.2 Target Organism                      

                                5.2.1 Introduction           

                                5.2.2 Antibacterial          

                                5.2.3 Antifungal

                                5.2.4 Antiviral   

                                5.2.5 Antiparasite           

                                5.2.6 others       

                                5.2.7 Y-o-Y Growth Analysis, By Target Organism               

                                5.2.8 Market Attractiveness Analysis, By Target Organism             

                                5.2.9 Market Share Analysis, By Target Organism              

                5.3 Infection type                           

                                5.3.1 Introduction           

                                5.3.2 Bacterial   

                                5.3.3 Viral           

                                5.3.4 Fungal       

                                5.3.5 parasitic   

                                5.3.6 others       

                                5.3.7 Y-o-Y Growth Analysis, By Infection type    

                                5.3.8 Market Attractiveness Analysis, By Infection type  

                                5.3.9 Market Share Analysis, By Infection Type   

                5.4 Distribution Channels                            

                                5.4.1 Hospitals  

                                5.4.2 Clinics        

                                5.4.3 Others      

                                5.4.4 Y-o-Y Growth Analysis, By Distribution Channels     

                                5.4.5 Market Attractiveness Analysis, By Distribution Channels   

                                5.4.6 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Mode of Treatment

                                                6.1.3.3 By Target organism

                                                6.1.3.4 By Infection Type

                                                6.1.3.5 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Mode of Treatment

                                                6.1.4.3 By Target organism

                                                6.1.4.4 By Infection Type

                                                6.1.4.5 By Distribution Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Mode of Treatment

                                                6.1.5.3 By Target organism

                                                6.1.5.4 By Infection Type

                                                6.1.5.5 By Distribution Channels

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Gilead Sciences                         

                8.3 GlaxoSmithKline                      

                8.4 Johnson & Johnson                 

                8.5 Merck & Co                

                8.6 Pfizer                            

                8.7 Achillion Pharmaceuticals                    

                8.8 Novartis                       

                8.9 Abbvie                         

                8.10 Astellas Pharma                     

                8.11 AstraZeneca                            

                8.12 Auritec Pharmaceuticals                     

                8.13 Bayer                          

                8.14 Bristol-Myers Squibb                           

                8.15 Chimerix Pharmaceuticals                 

                8.16 Cubist                         

                8.17 Eli Lilly                        

                8.18 Isis Pharmaceuticals                             

                8.19 pSivida                       

                8.20 Sanofi                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Middle East & Africa Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  2. Middle East & Africa Drugs Market, By Region, From 2020 to 2025 (USD Billion)
  3. Middle East & Africa vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  4. Middle East & Africa Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  5. Middle East & Africa Antibacterial Market, By Region, From 2020 to 2025 (USD Billion)
  6. Middle East & Africa Antifungal Market, By Region, From 2020 to 2025 (USD Billion)
  7. Middle East & Africa Antiviral Market, By Region, From 2020 to 2025 (USD Billion)
  8. Middle East & Africa Antiparasite Market, By Region, From 2020 to 2025 (USD Billion)
  9. Middle East & Africa Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  10. Middle East & Africa Bacterial Market, By Region, From 2020 to 2025 (USD Billion)
  11. Middle East & Africa Viral Market, By Region, From 2020 to 2025 (USD Billion)
  12. Middle East & Africa Fungal Market, By Region, From 2020 to 2025 (USD Billion)
  13. Middle East & Africa Parasitic Market, By Region, From 2020 to 2025 (USD Billion)
  14. Middle East & Africa Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  15. Middle East & Africa Hospitals Market, By Region, From 2020 to 2025 (USD Billion)
  16. Middle East & Africa Clinics Market, By Region, From 2020 to 2025 (USD Billion)
  17. Middle East Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  18. Middle East Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  19. Middle East Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  20. Middle East Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  21. Africa Infectious Disease Therapeutics Market, By Mode of treatment, From 2020 to 2025 (USD Billion)
  22. Africa Infectious Disease Therapeutics Market, By Target Organism, From 2020 to 2025 (USD Billion)
  23. Africa Infectious Disease Therapeutics Market, By Infection Type, From 2020 to 2025 (USD Billion)
  24. Africa Infectious Disease Therapeutics Market, By Distribution Channels, From 2020 to 2025 (USD Billion)
  25. Middle East & Africa Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  26. Middle East & Africa Oral Administration Market, By Region, From 2020 to 2025 (USD Billion)
  27. Middle East & Africa Topical Market, By Region, From 2020 to 2025 (USD Billion)
  28. Middle East & Africa Injections Market, By Region, From 2020 to 2025 (USD Billion)
  29. Middle East Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)
  30. Africa Infectious disease Therapeutics Market, By Drugs, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample